Skip to main content
. 2020 May 19;11:429. doi: 10.3389/fgene.2020.00429

TABLE 2.

Gene signature selected for model construction.

Probe Gene Coefficient Factor Expression level (high vs. low risk)
ENSG00000167740 CYB5D2 –0.244845303 Protective Decreased
ENSG00000188089 PLA2G4E –0.2109008 Protective Decreased
ENSG00000162458 FBLIM1 –0.199451582 Protective Decreased
ENSG00000104998 IL27RA –0.193108399 Protective Decreased
ENSG00000186838* SELENOV –0.168074864 Protective Decreased
ENSG00000231292 IGKV1OR2-108 –0.116666216 Protective Decreased
ENSG00000183914 DNAH2 –0.057694631 Protective Decreased
ENSG00000103888 CEMIP –0.054565913 Protective Decreased
ENSG00000180787 ZFP3 –0.021712839 Protective Decreased
ENSG00000275591 XKR5 –0.014694104 Protective Decreased
ENSG00000108100 CCNY 0.02622514 Risk Increased
ENSG00000107959 PITRM1 0.104753688 Risk Increased
ENSG00000176438 SYNE3 0.108748445 Risk Increased
ENSG00000004478 FKBP4 0.196424875 Risk Increased

*Excluded: no mapped gene in GLP570 platform. Gene names: Cytochrome B5 Domain Containing 2 (CYB5D2), Phospholipase A2 Group IVE (PLA2G4E), Filamin Binding LIM Protein 1 (FBLIM1), Interleukin 27 Receptor Subunit Alpha (IL27RA), Selenoprotein V (SELENOV), Immunoglobulin Kappa Variable 1/OR2-108 (IGKV1OR2-108), Dynein Axonemal Heavy Chain 2 (DNAH2), Cell Migration Inducing Hyaluronidase 1 (CEMIP), ZFP3 Zinc Finger Protein (ZFP3), XK Related 5 (XKR5), Cyclin Y (CCNY), Pitrilysin Metallopeptidase 1 (PITRM1), Spectrin Repeat Containing Nuclear Envelope Family Member 3 (SYNE3), and FKBP Prolyl Isomerase 4 (FKBP4).